Department of Pharmacy, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Department of Endocrinology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Front Endocrinol (Lausanne). 2022 Jul 11;13:905538. doi: 10.3389/fendo.2022.905538. eCollection 2022.
We aimed to examine the descriptive epidemiology and trends in the burden of type 2 diabetes mellitus (T2DM).
Data were extracted from the Global Burden of Disease 2019 dataset. Estimated annual percentage changes (EAPCs) were calculated to assess the trends in incidence rate, mortality and disability-adjusted life-years (DALYs) associated with T2DM. Measures were stratified by sex, region, country, age and social development index (SDI) value.
The global age-standardized incidence rate of T2DM increased from 1990 to 2019, with an EAPC of 1.25 (95% CI, 1.19 to 1.31). In 2019, the highest age-standardized incidence rate of T2DM was observed in high-SDI regions, and the largest increase in this rate from 1990 to 2019 was also in high-SDI regions (EAPC, 1.74;95% CI, 1.57 to 1.90). At the regional level, Central Asia (EAPC, 2.53;95% CI, 2.45 to 2.61) had the largest increase in the age-standardized incidence rate of T2DM from 1990 to 2019. At the national level, Luxembourg (EAPC, 4.51;95% CI, 4.37 to 4.65) and Uzbekistan (EAPC, 3.63; 95% CI, 3.44 to 3.82) had the largest increases in the age-standardized incidence rate of T2DM from 1990 to 2019. The global age-standardized death and DALY rates increased from 1990 to 2019, with EAPCs of 0.26 (95% CI, 0.16 to 0.37) and 0.81 (95% CI, 0.77 to 0.85), respectively. The age-standardized death and DALY rates showed the largest increases in Central Asia, South Asia and Southern Sub-Saharan Africa.
Globally, the age-standardized incidence, death and DALY rates increased from 1990 to 2019. Central Asia, South Asia and Southern Sub-Saharan Africa were found to have the greatest burden of T2DM. Future strategies should focus on these high-risk regions and other high-risk populations.
本研究旨在分析 2 型糖尿病(T2DM)的描述性流行病学和疾病负担变化趋势。
数据来源于 2019 年全球疾病负担研究。我们计算了发病率、死亡率和伤残调整生命年(DALY)的年度变化百分比(EAPC),以评估 T2DM 相关指标的变化趋势。我们按照性别、地区、国家、年龄和社会发展指数(SDI)进行分层。
全球年龄标准化 T2DM 发病率从 1990 年至 2019 年呈上升趋势,EAPC 为 1.25(95%置信区间,1.19 至 1.31)。2019 年,SDI 较高地区的年龄标准化 T2DM 发病率最高,该地区 T2DM 发病率从 1990 年至 2019 年的增幅也最大(EAPC,1.74;95%置信区间,1.57 至 1.90)。在区域层面上,中亚(EAPC,2.53;95%置信区间,2.45 至 2.61)是 1990 年至 2019 年 T2DM 发病率上升幅度最大的地区。在国家层面上,卢森堡(EAPC,4.51;95%置信区间,4.37 至 4.65)和乌兹别克斯坦(EAPC,3.63;95%置信区间,3.44 至 3.82)是 1990 年至 2019 年 T2DM 发病率上升幅度最大的国家。全球年龄标准化死亡率和 DALY 率从 1990 年至 2019 年呈上升趋势,EAPC 分别为 0.26(95%置信区间,0.16 至 0.37)和 0.81(95%置信区间,0.77 至 0.85)。年龄标准化死亡率和 DALY 率在中亚、南亚和撒哈拉以南非洲南部增幅最大。
全球范围内,1990 年至 2019 年 T2DM 的年龄标准化发病率、死亡率和 DALY 率均呈上升趋势。中亚、南亚和撒哈拉以南非洲南部是 T2DM 负担最重的地区。未来的防控策略应聚焦于这些高风险地区和其他高危人群。